Introduction
Methods
Study population
Potential strategies
Test characteristics and performance
Diagnostic accuracy
Feasibility
Prognostic Value
Cost-effectiveness analysis
Predictive Accuracy
Economic evaluation (Table 1)
Direct Costs | Indirect Costs | |||||
---|---|---|---|---|---|---|
Relative 3
| Absolute | Events | Morbidity | Mortality | Overall | |
c-TnT or I | 13,504
| |||||
treadmill exercise test | 1 | 140 | ||||
stress echocardiography | 2.1× | 294 | ||||
SPECT scintigraphy | 5.7× | 798 | ||||
Coronary Angiography | 21.7× | 3038 | ||||
Unstable Angina | 10.3013
| 5101
| 10.811 | |||
Acute Myocardial Infarction | 16.7813
| 11.5021
| 28.283 | |||
Heart Failure | 14.0901
| 11.5021
| 25.592 | |||
Cardiac Death | 10.4145
| 114.4841
| 124.898 | |||
Fatal Cancer | 50.5492
| 12.3092
| 75.3872
| 138.246 | ||
Non Fatal Cancer | 50.5492
| 12.3092
| 62.858 |
1) Direct costs (Table 1)
Average cost of cardiac imaging
Cost of c-TnT or c-TnI
2) Indirect costs (Table 1)
Average cost of unpredicted events
Economic and biological costs of cardiac imaging
Cost per patient correctly identified
Results
Strategy | Costs per strategy($) | Costs per patient correctly identified ($) | Costs per radiation exposure($) | Total Costs per strategy($) | Costs per patient correctly identified ($) |
---|---|---|---|---|---|
1. cTnI | 1.704.161 | 2.051 | 0 | 1.704.161 | 2.051 |
cTnT | 1.814.482 | 2.086 | 0 | 1.814.482 | 2.086 |
2. ex-ECG | 1.608.327 | 1890 | 0 | 1.608.327 | 1.890 |
3. ex-Echo | 750.282 | 803 | 0 | 750.282 | 803 |
4. PhSE | 525.495 | 533 | 0 | 525.495 | 533 |
5. ex-SPECT-TcS | 1.359.953 | 1521 | 100.552* | 1.460.505 | 1.634 |
6. CA | 5.548.794 | 29.673 | 60.939** | 5.609.733 | 29.999 |